Kivlahan D R, Heiman J R, Wright R C, Mundt J W, Shupe J A
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Hosp Community Psychiatry. 1991 Jun;42(6):609-14. doi: 10.1176/ps.42.6.609.
Retrospective self-report data from 60 chronic schizophrenic outpatients in a community support program (CSP) were used to study the relationship between a history of substance abuse and rate of psychiatric rehospitalization and outpatient treatment cost. The sample showed a significant overall reduction in days spent in a psychiatric hospital or jail and in outpatient treatment expenses during the first year in the CSP. Although subjects with recent symptoms of substance abuse (N = 27) showed consistently smaller reductions than subjects with no history of substance abuse (N = 17) or subjects with no recent substance abuse symptoms (N = 16), the only significant difference between the groups was in the total number of days spent in an institution. However, the findings suggest that treatment of patients with concurrent substance abuse and schizophrenia is disproportionately more costly than that of patients without dual diagnoses.
